61%
of retail accounts lose money when trading CFDs with this provider.
Investments involve risks and are not suitable for all investors. CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage.
61%
of retail investor accounts lose money when trading CFDs with this provider.
You should consider whether you understand how CFDs work, and whether you can afford to take the high risk of losing your money.
61%
of retail accounts lose money when trading CFDs with this provider.
Investments involve risks and are not suitable for all investors. CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage.
61%
of retail investor accounts lose money when trading CFDs with this provider.
You should consider whether you understand how CFDs work, and whether you can afford to take the high risk of losing your money.
English (International)
Artivion Inc
Closed
Sector Healthcare
28.5 0.96
Overview
Share price change
24h
Min
27.78
Max
28.51
Income | -2.3M |
|---|---|
Sales | 2.1M 96M |
EPS | -0.05 |
Profit margin | -2.389 |
Employees | 1,500 |
Recommendations | Strong Buy |
|---|---|
12 Months Forecast | +17.29 upside |
Next Earnings | 13 Feb 2025 |
|---|
Market Cap | 12M 892M |
|---|---|
Previous open | 27.54 |
Previous close | 28.5 |
News Sentiment
By Acuity
74%
26%
353 / 392 Healthcare
Artivion Inc Chart
Past performance is not a reliable indicator of future results.
Related News
Peer Comparison
Price change
Artivion Inc Forecast
Price Target
By TipRanks
17.29% upside
12 Months Forecast
Average 33.17 USD 17.29%
High 35 USD
Low 32 USD
Based on 6 Wall Street analysts offering 12 month price targets forArtivion Inc - Dist in the last 3 months.
Sentiment
By Acuity
353 / 392 Healthcare
News Sentiment
Bearish Evidence
Volatility
Below average
News Volume (RCV)
Above average
Financials
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$
About Artivion Inc
CryoLife, Inc. (CryoLife), is a medical device company. The Company is engaged in the manufacturing, processing, and distribution of medical devices and implantable human tissues used in cardiac and vascular surgical procedures for patients with aortic disease. The Company operates through two segments: Medical Devices and Preservation Services. The Medical Devices segment includes medical devices, such as Surgical Sealants, BioGlue products, JOTEC products, On-X products, CardioGenesis cardiac laser therapy, PhotoFix, and NEXUS. The Preservation Services segment includes services revenues from the preservation of cardiac and vascular implantable human tissues.
